TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
about
Association of FGFR2 rs2981582, SIRT1 rs12778366, STAT3 rs744166 gene polymorphisms with pituitary adenoma.Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylationFibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.Interactions between RASA2, CADM1, HIF1AN gene polymorphisms and body fatness with breast cancer: a population-based case-control study in China.
P2860
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@ast
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@en
type
label
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@ast
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@en
prefLabel
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@ast
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@en
P2093
P2860
P1476
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
@en
P2093
Chunying Shi
Qiyong Guo
P2860
P2888
P356
10.1186/S12957-016-0795-7
P577
2016-02-24T00:00:00Z
P5875
P6179
1035390606